143 related articles for article (PubMed ID: 2250172)
1. GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice.
Fazzini E; Durso R; Davoudi H; Szabo GK; Albert ML
J Neurol Sci; 1990 Oct; 99(1):59-68. PubMed ID: 2250172
[TBL] [Abstract][Full Text] [Related]
2. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
3. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
Hadjiconstantinou M; Neff NH
J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
[TBL] [Abstract][Full Text] [Related]
4. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
Schneider JS
J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
[TBL] [Abstract][Full Text] [Related]
5. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
[TBL] [Abstract][Full Text] [Related]
6. Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Schneider JS
Neuropharmacology; 1992 Feb; 31(2):185-92. PubMed ID: 1553028
[TBL] [Abstract][Full Text] [Related]
7. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
Schneider JS; Yuwiler A
Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism.
Schneider JS; DiStefano L
Neurology; 1994 Apr; 44(4):748-50. PubMed ID: 8164837
[TBL] [Abstract][Full Text] [Related]
9. Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion.
Schneider JS; Distefano L
Neuropharmacology; 1995 May; 34(5):489-93. PubMed ID: 7566482
[TBL] [Abstract][Full Text] [Related]
10. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.
Schneider JS; DiStefano L
Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
12. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
Johannessen JN; Sobotka TJ; Weise VK; Markey SP
J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
[TBL] [Abstract][Full Text] [Related]
13. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
Rothblat DS; Schneider JS
Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
[TBL] [Abstract][Full Text] [Related]
14. Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice.
Weihmuller FB; Hadjiconstantinou M; Bruno JP; Neff NH
Neurosci Lett; 1988 Oct; 92(2):207-12. PubMed ID: 2903475
[TBL] [Abstract][Full Text] [Related]
15. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
Date I; Felten SY; Felten DL
Neurosci Lett; 1989 Dec; 106(3):282-6. PubMed ID: 2601883
[TBL] [Abstract][Full Text] [Related]
16. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
[TBL] [Abstract][Full Text] [Related]
17. Increase of striatal dopamine turnover by stress in MPTP-treated mice.
Urakami K; Masaki N; Shimoda K; Nishikawa S; Takahashi K
Clin Neuropharmacol; 1988 Aug; 11(4):360-8. PubMed ID: 3264755
[TBL] [Abstract][Full Text] [Related]
18. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
Date I; Asari S; Nishimoto A; Felten DL
No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
[TBL] [Abstract][Full Text] [Related]
19. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
Rothblat DS; Schneider JS
Ann N Y Acad Sci; 1998 Jun; 845():274-7. PubMed ID: 9668361
[TBL] [Abstract][Full Text] [Related]
20. Increased striatal dopamine turnover following acute administration of rotenone to mice.
Thiffault C; Langston JW; Di Monte DA
Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
